MYOS Canine Muscle Formula - Blog
-
PRESS RELEASE: MYOS CORP Announces Peer Reviewed Study on The Impact of Fortetropin in Arthritic Dogs Has Been Accepted for Publication
MYOS CORP Announces Peer Reviewed Study on The Impact of Fortetropin in Arthritic Dogs Has Been Accepted for Publication Dogs Supplemented with Fortetropin® Experienced Clinically Significant Improvements in Osteoarthritis CEDAR KNOLLS, N.J., March 29, 2022-- MYOS CORP, a research-based, advanced nutrition company, announces that a new peer... -
PRESS RELEASE: MYOS CORP Announces Positive Results from Feline Study on Fortetropin
Results of Study at University of Florida Form Basis for Company's Entry into Feline Market with Launch of MYOS Feline Muscle Health Formula. CEDAR KNOLLS, N.J., June 15, 2021 /PRNewswire/ -- MYOS Corp ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, anno... -
PRESS RELEASE: MYOS CORP to Attend VMX In Person, Will Introduce Three Products, Two Clinical Studies, and Vet Advisory Board
Company will share exciting updates with animal health industry leaders at Booth #2442 CEDAR KNOLLS, N.J., June 1, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced today that it will be attending in-person the 2021... -
PRESS RELEASE: MYOS CORP Announces Partnership with Animal Health Distribution Leader, Patterson Veterinary
Partnership will allow for scaling of Company's thriving Direct-to-Vet business throughout North America CEDAR KNOLLS, N.J., March 18, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced today that it has entered a pa... -
PRESS RELEASE: MYOS CORP Announces Formation of Veterinary Advisory Board
Seven prestigious thought leaders from private practice and academia will guide MYOS CORP through its next stage of growth in animal health industry. CEDAR KNOLLS, N.J., Feb. 2, 2021 /PRNewswire/ -- MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health,... -
PRESS RELEASE: MYOS CORP Announces Positive Results from Mobility and Quality of Life Study in Geriatric and Arthritic Dogs at Kansas State University
Dogs Supplemented with Fortetropin® Experienced Statistically Significant Improvements in LOAD (Liverpool Osteoarthritis in Dogs) Scores CEDAR KNOLLS, N.J., Dec. 9, 2020 /PRNewswire/ -- MYOS Corp,a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced positive results today from a... -
MYOS RENS Announces that Multiple Top-Tier Pet Insurance Companies Now Cover its Canine Nutrition Products
Science-Backed Product is Recommended by Key Opinion Leaders in Veterinary Medicine. CEDAR KNOLLS, N.J., April 28, 2020 /PR Newswire/-- MYOS RENS Technology Inc. (“MYOS” or “the Company”) (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, announced today that it... -
MYOS RENS Announces Publication of Landmark Clinical Study on Recovery in Dogs Following TPLO Surgery
100-Dog Study Showed that Dogs Receiving Fortetropin® Experienced Reduced Muscle Loss and Improved Recovery
E-Newsletter
Join our community of dog lovers at MYOS Pet. We are dedicated to providing valuable resource articles as well as publishing dog health, nutrition tips & posts.